Sassi G, Licata G, Ventriglia G, Wouters A, et al. A plasma miR-193b-365 signature combined with age and glycemic status predicts response to Lactococcus lactis-based antigen-specific immunotherapy in new-onset type 1 diabetes. Diabetes 2023 Jul 26:db220852. doi: 10.2337/db22-0852.
PMID: 37494666